MedTrace Logo

Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents

NCT01966055 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2017-02-23

No results posted yet for this study

Summary

A study of the safety and pharmacokinetics of solithromycin capsules in adolescents

Conditions

Interventions

DRUG

Solithromycin

Sponsors & Collaborators

Principal Investigators

  • Michael Cohen-Wolkowiez, MD · Duke Clinical Research Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-08-31
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01966055 on ClinicalTrials.gov